WHO ICTRP trial
A prospective, multicenter, open-label, observation study evaluating the…
KCT0004697 · Clinical Research Information Service (CRIS) · Recruiting
Key facts
| Trial ID | KCT0004697 |
|---|---|
| Public title | A prospective, multicenter, open-label, observation study evaluating the efficacy and safety of edoxaban in patients with cancer-associated venous thromboembolism |
| Scientific title | A prospective, multicenter, open-label, observation study evaluating the efficacy and safety of edoxaban in patients with cancer-associated venous thromboembolism |
| Primary sponsor | Yonsei University Health System, Severance Hospital |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Recruiting |
| Study type | Observational Study |
| Countries | Korea, Republic of |
| Conditions | Neoplasms |
| Registration date | Feb 4, 2020 |
| Target size | 300 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: